Amyotrophic lateral sclerosis research program support services for the congressionally directed medical research programs
Ended Awarded Last action
- Contract number
- HT942523F0096
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $230,270
Award facts
- Opportunity
-
- Meeting, Programmatic, and Administrative Support Services Pre-Solicitation · W81XWH22R0025 · Posted Aug 16, 2021
- Contract value 90% obligated
- $254,774.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$5,325 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $5,995 | |
| Funding Only Action | $19,558 | |
| Funding Only Action | $117,248 | |
| Other Administrative Action | $0 | |
| Original award | $92,794 |
About this award
This is a delivery order contract awarded to Leidos, Inc. under the Congressionally Directed Medical Research Programs (CDMRP) to provide support services for the Amyotrophic Lateral Sclerosis (ALS) Research Program. The contract, with a ceiling value of $254,774.59, was awarded on May 1, 2023, by the Defense Health Agency (DHA), a defense agency, and has an ultimate completion date of April 30, 2024. The contract is a cost-plus-fixed-fee type, and there is no set-aside designation. Leidos, Inc. is the prime contractor, and the award is associated with a larger Indefinite Delivery Vehicle (IDV) contract. The ALS Research Program is part of the CDMRP, which funds medical research on various conditions, including traumatic brain injury, cancer, autism, and rare diseases, in support of the U.S. Department of Defense.
Quick answers
Who was awarded contract HT942523F0096?
HT942523F0096 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on May 1, 2023.
How much is contract HT942523F0096 worth?
The government has obligated $230,270 on HT942523F0096. Its current value, with exercised options, is $254,775.
Is contract HT942523F0096 an order under another contract?
Yes. HT942523F0096 is a delivery order under HT942523D0002, an indefinite delivery contract.
Was contract HT942523F0096 competed?
The extent of competition for HT942523F0096 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award